Market Overview:
The global semi automated coagulation analyzer market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing demand for point-of-care testing, rising prevalence of diseases, and technological advancements in coagulation analyzers. Based on type, the global semi automated coagulation analyzer market is segmented into benchtop and handheld devices. The benchtop devices segment is expected to account for the majority share of the global semi automated coagulation analyzer market in 2018. This can be attributed to their high accuracy and reliability as compared to handheld devices. Based on application, the global semi automated coagulation analyzer market is segmented into hospitals, research institutes, diagnostic centers, and others (including blood banks and military establishments). The hospitals segment accounted for the majority share of the global semi automated coagulation analyzer market in 2017 and is projected to grow at a CAGR of 5.8% during the forecast period from 2018to 2030 owingtothe increasing demand for point-of-care testingin this sector .
Product Definition:
A semi automated coagulation analyzer is a machine that is used to measure the amount of clotting in a patient's blood. This machine is important because it can help doctors to determine how well a patient's blood is clotting and whether they may be at risk for developing a clot.
Benchtop:
The global benchtop coagulation analyzers market was valued at USD 1.6 billion in 2016 and is expected to grow at a CAGR of XX% over the forecast period. The increasing prevalence of chronic diseases such as cancer, cardiovascular disorders, and diabetes are some major factors driving the growth of this market during the forecast period 2016-2021.
Handheld:
Handheld devices are used in semi automated coagulation analyzers for the collection of blood samples. These devices are portable and can be easily operated by medical laboratory technicians without any special training. Handheld device is a combination of two instruments, which consists of an lancet and a meter or pen.
Application Insights:
Based on application, the market is segmented into hospitals, research institutes, diagnostic centers and others. Hospitals are expected to be at the forefront of adoption owing to their superior ability to cope with emergencies and traumatic cases. Automated coagulation analyzers have been proven effective in reducing trauma cases by enabling quick identification of blood clots before they develop into life-threatening situations. As a result, hospitals are likely to remain key end users of such devices over the forecast period.
Research Institutes also play an important role in promoting new product development as well as improving existing products based on customer requirements and feedbacks obtained from clinical trials performed at various Research Institutes across the world.
Regional Analysis:
North America dominated the global semi automated coagulation analyzer market in 2017. This can be attributed to the presence of major players, high adoption rate of advanced technologies and increasing healthcare expenditure in U.S. Moreover, favorable reimbursement policies are also expected to drive growth over the forecast period.
Growth Factors:
- Increasing demand for early diagnosis of diseases: The global semi automated coagulation analyzer market is expected to grow at a CAGR of 7.5% during the forecast period owing to the increasing demand for early diagnosis of diseases. This is mainly because semi automated coagulation analyzers offer accurate and rapid results, which helps in timely treatment of patients.
- Technological advancements: The market is witnessing technological advancements in terms of product offerings, which is aiding the growth of the market. For instance, manufacturers are offering products that can provide results within minutes and are portable as well, thereby making them easy to use in remote areas or emergency situations.
- Rising prevalence of chronic diseases: The rising prevalence of chronic diseases such as cancer, heart disease, and diabetes is driving the demand for semi automated coagulation analyzers globally as these devices play an important role in diagnosing these conditions accurately and quickly.
Scope Of The Report
Report Attributes
Report Details
Report Title
Semi Automated Coagulation Analyzer Market Research Report
By Type
Benchtop, Handheld
By Application
Hospitals, Research Institutes, Diagnostic Centers, Others
By Companies
Genrui Biotech Inc., Horiba, Erba Group(ERBA Diagnostics Mannheim), Human, Meril Life Sciences, TECO Medical Instruments, A & T Corporation, Maccura Biotechnology, Dialab, iLine Microsystems, Cypress Diagnostics, Succeeder
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
137
Number of Tables & Figures
96
Customization Available
Yes, the report can be customized as per your need.
Global Semi Automated Coagulation Analyzer Market Report Segments:
The global Semi Automated Coagulation Analyzer market is segmented on the basis of:
Types
Benchtop, Handheld
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Research Institutes, Diagnostic Centers, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Genrui Biotech Inc.
- Horiba
- Erba Group(ERBA Diagnostics Mannheim)
- Human
- Meril Life Sciences
- TECO Medical Instruments
- A & T Corporation
- Maccura Biotechnology
- Dialab
- iLine Microsystems
- Cypress Diagnostics
- Succeeder
Highlights of The Semi Automated Coagulation Analyzer Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Benchtop
- Handheld
- By Application:
- Hospitals
- Research Institutes
- Diagnostic Centers
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Semi Automated Coagulation Analyzer Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Semi-automated coagulation analyzer is a device that helps in the detection of blood clots. It uses a combination of ultrasound and light to measure the size, shape, and movement of clots. This information is then used to determine if there is an increased risk for stroke or heart attack.
Some of the key players operating in the semi automated coagulation analyzer market are Genrui Biotech Inc., Horiba, Erba Group(ERBA Diagnostics Mannheim), Human, Meril Life Sciences, TECO Medical Instruments, A & T Corporation, Maccura Biotechnology, Dialab, iLine Microsystems, Cypress Diagnostics, Succeeder.
The semi automated coagulation analyzer market is expected to register a CAGR of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Semi Automated Coagulation Analyzer Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Semi Automated Coagulation Analyzer Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Semi Automated Coagulation Analyzer Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Semi Automated Coagulation Analyzer Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Semi Automated Coagulation Analyzer Market Size & Forecast, 2020-2028
4.5.1 Semi Automated Coagulation Analyzer Market Size and Y-o-Y Growth
4.5.2 Semi Automated Coagulation Analyzer Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Benchtop
5.2.2 Handheld
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Research Institutes
6.2.3 Diagnostic Centers
6.2.4 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Semi Automated Coagulation Analyzer Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Semi Automated Coagulation Analyzer Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Benchtop
9.6.2 Handheld
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Research Institutes
9.10.3 Diagnostic Centers
9.10.4 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Benchtop
10.6.2 Handheld
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Research Institutes
10.10.3 Diagnostic Centers
10.10.4 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Benchtop
11.6.2 Handheld
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Research Institutes
11.10.3 Diagnostic Centers
11.10.4 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Benchtop
12.6.2 Handheld
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Research Institutes
12.10.3 Diagnostic Centers
12.10.4 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Benchtop
13.6.2 Handheld
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Research Institutes
13.10.3 Diagnostic Centers
13.10.4 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Semi Automated Coagulation Analyzer Market: Competitive Dashboard
14.2 Global Semi Automated Coagulation Analyzer Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Genrui Biotech Inc.
14.3.2 Horiba
14.3.3 Erba Group(ERBA Diagnostics Mannheim)
14.3.4 Human
14.3.5 Meril Life Sciences
14.3.6 TECO Medical Instruments
14.3.7 A & T Corporation
14.3.8 Maccura Biotechnology
14.3.9 Dialab
14.3.10 iLine Microsystems
14.3.11 Cypress Diagnostics
14.3.12 Succeeder
